Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection

Journal of Immunology

Volumn 163, Issue 10, 1999, Pages 5735-5740

  Hoshino, Yo ^a,b   Morishima, Tsuneo ^b   Kimura, Hiroshi ^b   Nishikawa, Kazuo ^c   Tsurumi, Tatsuya ^a   Kuzushima, Kiyotaka ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Nagoya Ekisaikai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEVER; HLA SYSTEM; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ANTIGENS, CD45; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; EPITOPES, T-LYMPHOCYTE; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ANTIGENS; HUMANS; INFECTIOUS MONONUCLEOSIS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; VIRAL LOAD;

EID: 0033571074     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus. In Fields Virology, Vol. 2, 3rd Ed., B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 2397.
2. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405.
3. Steven, N. M., N. E. Annels, A. Kumar, A. M. Leese, M. G. Kurilla, and A. B. Rickinson. 1997. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185:1605.
4. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
5. Tomkinson, B. E., D. K. Wagner, D. L. Nelson, and J. L. Sullivan. 1987. Activated lymphocytes during acute Epstein-Barr virus infection. J. Exp. Med. 139: 3802.
6. + T cells as a sign of in vivo activation in infectious mononucleosis. Clin. Exp. Immunol. 83:447.
7. + T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 80:452.
8. Oldstone, M. B. A. 1987. Molecular mimicry and autoimmune disease. Cell 50:819.
9. Beverley, P. C. 1990. Is T-cell memory maintained by cross-reactive stimulation ? Immunol. Today 11:203.
10. Unutmaz, D., P. Pileri, and S. Abrignani. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 180:1159.
11. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947.
12. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
13. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.
14. Zinkernagel, R. M., M. F. Bachmann, T. M. Kundig, S. Oehen, H. Pircher, and H. Hengartner. 1996. On immunological memory. Annu. Rev. Immunol. 14:333.
15. Steven, N. M., A. M. Leese, N. E. Annels, S. P. Lee, and A. B. Rickinson. 1996. Epitope focusing on the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med. 184:1801.
16. + T cells in acute infectious mononucleosis. Nat. Med. 2:906.
17. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395.
18. + T cell frequencies by flow cytometry. Blood, In press.
19. Scotet, E., J. David-Ameline, M. A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J. M. Berthelot, R. Breathnach, et al. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis J. Exp. Med. 184:1791.
20. Kuzushima, K., M. Yamamoto, H. Kimura, Y. Ando, T. Kudo, I. Tsuge, and T. Morishima. 1996. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin. Exp. Immunol. 103:192.
21. Kimura, H., M. Morita, Y. Yabuta, K. Kuzushima, K. Kato, S. Kojima, T. Matsuyama, and T. Morishima. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 37:132.
22. Sutkowski, N., T. Palkama, C. Ciurli, R. P. Sekaly, D. A. Thorley-Lawson, and B. T. Huber. 1996. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184:971.
23. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
24. Strang, G., and A. B. Rickinson. 1987. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Eur. J. Immunol. 17:1007.
25. De Waele, M., C. Thielemans, and B. K. G. van Camp. 1981. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N. Engl. J. Med. 304:460.
26. Oehen, S., H. Waldner, T. M. Kundig, H. Hengartner, and R. M. Zinkernagel. 1992. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J. Exp. Med 176:1273.
27. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
28. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
29. Heslop, H. E., C. Y. Ng, C. Li, C. A. Smith, S. K. Loftin, R. A. Krance, M. K. Brenner, and C. M. Rooney. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2:551.
30. Haque, T., P. L. Amlot, N. Helling, J. A. Thomas, P. Sweny, K. Rolles, A. K. Burroughs, H. G. Prentice, and D. H. Crawford. 1998. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J. Immunol. 160:6204.
31. Roskrow, M. A., N. Suzuki, Y. J. Gan, J. W. Sixbey, C. Y. Ng, S. Kimbrough, M. Hudson, M. K. Brenner, H. E. Heslop, and C. M. Rooney. 1998. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 91:2925.
32. Sugiura, M., S. Imai, M. Tokunaga, S. Koizumi, M. Uchizawa, K. Okamoto, and T. Osato. 1996. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br. J. Cancer 74:625.
33. Okano, M., and T. G. Gross. 1996. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am. J. Hematol. 53:111.
34. Okano, M., S. Matsumoto, T. Osato, Y. Sakiyama, G. M. Thiele, and D. T. Purtilo. 1991. Severe chronic active Epstein-Barr virus infection syndrome. Clin. Microbiol. Rev. 4:129.
35. Ohshima, K., J. Suzumiya, M. Sugihara, S. Nagafuchi, S. Ohga, and M. Kikuchi. 1998. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome. Pathol. Int. 48:934.